Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

NYSE:NXRT - New York Stock Exchange, Inc. - US65341D1028 - REIT - Currency: USD

34.6  -1.44 (-4%)

Fundamental Rating

3

NXRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. The financial health of NXRT is average, but there are quite some concerns on its profitability. NXRT does not seem to be growing, but still is valued expensively. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NXRT has reported negative net income.
In the past year NXRT had a positive cash flow from operations.
NXRT had positive earnings in 4 of the past 5 years.
In the past 5 years NXRT always reported a positive cash flow from operatings.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

NXRT has a Return On Assets of -1.71%. This is amonst the worse of the industry: NXRT underperforms 90.00% of its industry peers.
The Return On Equity of NXRT (-8.45%) is worse than 85.00% of its industry peers.
NXRT's Return On Invested Capital of 1.20% is on the low side compared to the rest of the industry. NXRT is outperformed by 70.00% of its industry peers.
NXRT had an Average Return On Invested Capital over the past 3 years of 1.37%. This is in line with the industry average of 2.75%.
Industry RankSector Rank
ROA -1.71%
ROE -8.45%
ROIC 1.2%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

NXRT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.03%, NXRT is doing worse than 75.00% of the companies in the same industry.
NXRT's Operating Margin has improved in the last couple of years.
The Gross Margin of NXRT (94.44%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of NXRT has remained more or less at the same level.
Industry RankSector Rank
OM 11.03%
PM (TTM) N/A
GM 94.44%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y0.28%
GM growth 5Y0.34%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NXRT is destroying value.
NXRT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXRT has more shares outstanding
Compared to 1 year ago, NXRT has a worse debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

NXRT has an Altman-Z score of 0.52. This is a bad value and indicates that NXRT is not financially healthy and even has some risk of bankruptcy.
NXRT has a worse Altman-Z score (0.52) than 65.00% of its industry peers.
NXRT has a debt to FCF ratio of 32.10. This is a negative value and a sign of low solvency as NXRT would need 32.10 years to pay back of all of its debts.
NXRT has a Debt to FCF ratio of 32.10. This is in the better half of the industry: NXRT outperforms 65.00% of its industry peers.
A Debt/Equity ratio of 3.86 is on the high side and indicates that NXRT has dependencies on debt financing.
With a Debt to Equity ratio value of 3.86, NXRT is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF 32.1
Altman-Z 0.52
ROIC/WACC0.15
WACC7.87%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.45 indicates that NXRT should not have too much problems paying its short term obligations.
NXRT has a Current ratio of 1.45. This is amongst the best in the industry. NXRT outperforms 95.00% of its industry peers.
NXRT has a Quick Ratio of 1.45. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NXRT (1.45) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

NXRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -206.84%.
The earnings per share for NXRT have been decreasing by -65.41% on average. This is quite bad
NXRT shows a decrease in Revenue. In the last year, the revenue decreased by -7.44%.
Measured over the past years, NXRT shows a small growth in Revenue. The Revenue has been growing by 7.48% on average per year.
EPS 1Y (TTM)-206.84%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%-127%
Revenue 1Y (TTM)-7.44%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-22.08%

3.2 Future

Based on estimates for the next years, NXRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -276.83% on average per year.
Based on estimates for the next years, NXRT will show a small growth in Revenue. The Revenue will grow by 3.23% on average per year.
EPS Next Y-5954.8%
EPS Next 2Y-671.38%
EPS Next 3Y-276.83%
EPS Next 5YN/A
Revenue Next Year-1.54%
Revenue Next 2Y1.87%
Revenue Next 3Y3.14%
Revenue Next 5Y3.23%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

80.00% of the companies in the same industry are more expensive than NXRT, based on the Enterprise Value to EBITDA ratio.
90.00% of the companies in the same industry are more expensive than NXRT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.38
EV/EBITDA 18.76
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

NXRT's earnings are expected to decrease with -276.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-671.38%
EPS Next 3Y-276.83%

7

5. Dividend

5.1 Amount

NXRT has a Yearly Dividend Yield of 5.59%, which is a nice return.
Compared to an average industry Dividend Yield of 4.43, NXRT pays a better dividend. On top of this NXRT pays more dividend than 85.00% of the companies listed in the same industry.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 5.59%

5.2 History

On average, the dividend of NXRT grows each year by 10.88%, which is quite nice.
NXRT has been paying a dividend for at least 10 years, so it has a reliable track record.
NXRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

NXRT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-157.7%
EPS Next 2Y-671.38%
EPS Next 3Y-276.83%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (5/21/2025, 3:21:45 PM)

34.6

-1.44 (-4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners79.85%
Inst Owner Change-1.77%
Ins Owners12.19%
Ins Owner Change13.91%
Market Cap884.72M
Analysts78.46
Price Target43.73 (26.39%)
Short Float %1.54%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 5.59%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-157.7%
Div Incr Years9
Div Non Decr Years9
Ex-Date06-16 2025-06-16 (0.51)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-83.7%
Min EPS beat(2)-176.12%
Max EPS beat(2)8.72%
EPS beat(4)2
Avg EPS beat(4)42.47%
Min EPS beat(4)-176.12%
Max EPS beat(4)364.38%
EPS beat(8)4
Avg EPS beat(8)34.81%
EPS beat(12)5
Avg EPS beat(12)5.61%
EPS beat(16)9
Avg EPS beat(16)54.71%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)16.56%
Revenue beat(8)2
Avg Revenue beat(8)3.13%
Revenue beat(12)4
Avg Revenue beat(12)2.07%
Revenue beat(16)6
Avg Revenue beat(16)1.31%
PT rev (1m)-3.65%
PT rev (3m)-6.54%
EPS NQ rev (1m)-4.14%
EPS NQ rev (3m)-10.49%
EPS NY rev (1m)-2.5%
EPS NY rev (3m)-7.43%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)-2.08%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.46
P/FCF 19.38
P/OCF 10.76
P/B 2.33
P/tB 2.33
EV/EBITDA 18.76
EPS(TTM)-1.25
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)1.78
FCFY5.16%
OCF(TTM)3.22
OCFY9.29%
SpS9.99
BVpS14.86
TBVpS14.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.71%
ROE -8.45%
ROCE 1.52%
ROIC 1.2%
ROICexc 1.21%
ROICexgc 1.24%
OM 11.03%
PM (TTM) N/A
GM 94.44%
FCFM 17.87%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexcg growth 3Y22.72%
ROICexcg growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y0.28%
GM growth 5Y0.34%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF 32.1
Debt/EBITDA 11.63
Cap/Depr 37.39%
Cap/Sales 14.32%
Interest Coverage 0.28
Cash Conversion 65.27%
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 0.52
F-Score4
WACC7.87%
ROIC/WACC0.15
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-206.84%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%-127%
EPS Next Y-5954.8%
EPS Next 2Y-671.38%
EPS Next 3Y-276.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.44%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-22.08%
Revenue Next Year-1.54%
Revenue Next 2Y1.87%
Revenue Next 3Y3.14%
Revenue Next 5Y3.23%
EBIT growth 1Y-31.21%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18732.6%
EBIT Next 3Y502.75%
EBIT Next 5Y289.52%
FCF growth 1Y140.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.4%
OCF growth 3Y0.14%
OCF growth 5Y7.45%